Autoimmunity against desmosomal cadherins in pemphigus

Journal of Dermatological Science

Volumn 20, Issue 2, 1999, Pages 92-102

  Amagai, Masayuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmunity; Desmosomal cadherins; Pemphigus

Indexed keywords

AUTOANTIBODY; CADHERIN; DESMOCOLLIN; DESMOGLEIN; DESMOPLAKIN; ENVOPLAKIN; IMMUNOGLOBULIN G; PERIPLAKIN; PLECTIN;

ANTIBODY PRODUCTION; AUTOIMMUNITY; BLISTER; CONFERENCE PAPER; DESMOSOME; HUMAN; MUCOSA; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS; TISSUE SPECIFICITY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CADHERINS; DESMOSOMES; HUMANS; PEMPHIGUS;

EID: 0033010864     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00016-X     Document Type: Conference Paper

References (52)

1. Stanley J.R. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol. 53:1993;291-325.
2. Amagai M. Adhesion molecules I: keratinocyte-keratinocyte interactions, cadherins and pemphigus. J Invest Dermatol. 104:1995;146-152.
3. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol. 11:1996;319-352.
4. Stanley J.R., Yaar M., Hawley N.P., Katz S.I. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest. 70:1982;281-288.
5. Stanley J.R., Koulu L., Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest. 74:1984;313-320.
6. Eyre R.W., Stanley J.R. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest. 81:1988;807-812.
7. Hashimoto T., Ogawa M.M., Konohana A., Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol. 94:1990;327-331.
8. Amagai M., Klaus-Kovtun V., Stanley J.R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 67:1991;869-877.
9. Koch P.J., Walsh M.J., Schmelz M., Goldschmidt M.D., Zimbelmann R., Franke W.W. Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules. Eur J Cell Biol. 53:1990;1-12.
10. Nilles L.A., Parry D., Powers E.E., Angst B.D., Wagner R.M., Green K.J. Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome. J Cell Sci. 99:1991;809-821.
11. Schafer S., Koch P.J., Franke W.W. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp Cell Res. 211:1994;391-399.
12. Emery D.J., Diaz L.A., Fairley J.A., Lopez A., Taylor A.F., Giudice G.J. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol. 104:1995;323-328.
13. Kowalczyk A.P., Anderson J.E., Borgwardt J.E., Hashimoto T., Stanley J.R., Green K.J. Pemphigus sera recognize conformationally sensitive epitopes in the amino-terminal region of desmoglein-1 (Dsg1). J Invest Dermatol. 105:1995;147-152.
14. Eyre R.W., Stanley J.R. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J Exp Med. 165:1987;1719-1724.
15. Amagai M., Hashimoto T., Green K.J., Shimizu N., Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 104:1995;895-901.
16. Ishii K., Amagai M., Hall R.P. et al. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins. J Immunol. 159:1997;2010-2017.
17. Amagai M., Tsunoda K., Zillikens D., Nagai T., Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol. 40:1999;167-170.
18. Ding X., Aoki V., Mascaro J.M., Lopez-Swiderski A., Diaz L.A., Fairley J.A. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol. 109:1997;592-596.
19. Mahoney M.G., Wang Z., Rothenberger K.L., Koch P.J., Amagai M., Stanley J.R. Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 103:1999;461-468.
20. Anhalt G.J., Labib R.S., Voorhees J.J., Beals T.F., Diaz L.A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. New Engl J Med. 306:1982;1189-1196.
21. Amagai M., Koch P.J., Nishikawa T., Stanley J.R. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 106:1996;351-355.
22. Shirakata Y., Amagai M., Hanakawa Y., Nishikawa T., Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein1. J Invest Dermatol. 110:1998;76-78.
23. Jablonska S., Chorzelski T.P., Beutner E.H., Chorselska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol. 14:1975;353-359.
24. Verdier-Sevrain S., Joly P., Thomine E. et al. Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectron microscopy and immunoblot analysis. Br J Dermatol. 130:1994;238-240.
25. Shimizu K., Hashimoto T., Wang N. et al. A case of herpetiform pemphigus associated with autoimmune hemolytic anemia: detection of autoantibodies against multiple epidermal antigens. Dermatology. 192:1996;179-182.
26. Santi C.G., Murata C.W., Aoki V., Sotto M.N., Rivitti E.A., Diaz L.A. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. J Am Acad Dermatol. 34:1996;40-46.
27. Kubo A., Amagai M., Hashimoto T. et al. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3). Br J Dermatol. 137:1997;109-113.
28. Ishii K, Amagai M, Komai A et al. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol (in press).
29. Anhalt G.J., Kim S., Stanley J.R. et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. New Engl J Med. 323:1990;1729-1735.
30. Anhalt G.J. Paraneoplastic pemphigus. Adv Dermatol. 12:1997;77-97.
31. Oursler J.R., Labib R.S., Ariss A.L., Burke T., O'Keefe E.J., Anhalt G.J. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest. 89:1992;1775-1782.
32. Hashimoto T., Amagai M., Watanabe K. et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol. 104:1995;829-834.
33. Kim S.C., Kwon Y.D., Lee I.J., Chang S.N., Lee T.G. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol. 109:1997;365-369.
34. Ruhrberg C., Hajibagheri M.A., Simon M., Dooley T.P., Watt F.M. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol. 134:1996;715-729.
35. Ruhrberg C., Hajibagheri M.A.N., Parry D.A.D., Watt F.M. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol. 139:1997;1835-1849.
36. Mahoney M.G., Aho S., Uitto J., Stanley J.R. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol. 111:1998;308-313.
37. Borradori L., Trueb R.M., Jaunin F., Limat A., Favre B., Saurat J.-H. Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol. 111:1998;338-340. (Letter).
38. Kiyokawa C., Ruhrberg C., Karashima T. et al. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex (Letter). J Invest Dermatol. 111:1998;1236-1238.
39. Ruhrberg C., Watt F.M. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev. 7:1997;392-397.
40. Joly P., Thomine E., Gilbert D. et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol. 103:1994;65-72.
41. Hashimoto T., Amagai M., Wang N. et al. Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus. J Dermatol Sci. 17:1998;132-139.
42. Amagai M., Nishikawa T., Nousari H.C., Anhalt G.J., Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 102:1998;775-782.
43. Tagami H., Iwatsuki K., Iwase Y., Yamada M. Subcorneal pustular dermatosis with vesiculo-bullous eruption: demonstration of subcorneal IgA deposits and a leukocyte chemotactic factor. Br J Dermatol. 109:1983;581-587.
44. Huff J.C., Golitz L.E., Kunke K.S. Intraepidermal neutrophilic IgA dermatosis. New Engl J Med. 313:1985;1643-1645.
45. Beutner E.H., Chorzelski T.P., Wilson R.M. et al. IgA pemphigus foliaceus. Report of two cases and a review of the literature. J Am Acad Dermatol. 20:1989;89-97.
46. Ebihara T., Hashimoto T., Iwatsuki K. et al. Autoantigens for IgA anti-intercellular antibodies of intercellular IgA vesiculopustular dermatosis. J Invest Dermatol. 97:1991;742-745.
47. Hashimoto T., Kiyokawa C., Mori O. et al. Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol. 109:1997;127-131.
48. Wang J., Kwon J., Ding X., Fairley J.A., Woodley D.T., Chan L.S. Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol. 150:1997;1901-1907.
49. Wucherpfennig K.W., Yu B., Bhol K. et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA. 92:1995;11935-11939.
50. Lin M.S., Swartz S.J., Lopez A. et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest. 99:1997;31-40.
51. Hertl M., Amagai M., Sundaram H., Stanley J.R., Ishii K., Katz S.I. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol. 110:1998;62-66.
52. Hertl M., Karr R.W., Amagai M., Katz S.I. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J Invest Dermatol. 110:1998;388-392.